Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus.

× No keyword cloud information.

4 in total

Review 1. Etanercept (Enbrel): update on therapeutic use.

Authors: G Spencer-Green
Journal: Ann Rheum Dis Date: 2000-11 Impact factor: 19.103

2. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

Authors: M A Gonzalez-Gay; J M De Matias; C Gonzalez-Juanatey; C Garcia-Porrua; A Sanchez-Andrade; J Martin; J Llorca
Journal: Clin Exp Rheumatol Date: 2006 Jan-Feb Impact factor: 4.473

3. Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages.

Authors: N Satomi; A Sakurai; K Haranaka
Journal: J Natl Cancer Inst Date: 1985-06 Impact factor: 13.506

4. Metabolic effects of tumour necrosis factor alpha in NMRI mice.

Authors: S M Mahony; M J Tisdale
Journal: Br J Cancer Date: 1990-04 Impact factor: 7.640

4 in total

11 in total

1. Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.

Authors: Sukhmani Pannu; David Rosmarin
Journal: Am J Clin Dermatol Date: 2021-02-15 Impact factor: 7.403

Review 2. Drug-induced hypoglycaemia: an update.

Authors: Chaker Ben Salem; Neila Fathallah; Houssem Hmouda; Kamel Bouraoui
Journal: Drug Saf Date: 2011-01-01 Impact factor: 5.606

Review 3. Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors: Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal: Curr Diab Rep Date: 2016-10 Impact factor: 4.810

4. Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series.

Authors: Jadwiga B Czajkowska; Brandon Shutty; Susan Zito
Journal: J Med Case Rep Date: 2012-01-10

5. Refractory rheumatoid factor positive polyarthritis in a female adolescent already suffering from type 1 diabetes mellitus and Hashimoto's thyroiditis successfully treated with etanercept.

Authors: Alma Nunzia Olivieri; Dario Iafusco; Antonio Mellos; Angela Zanfardino; Angela Mauro; Carmela Granato; Maria Francesca Gicchino; Francesco Prisco; Laura Perrone
Journal: Ital J Pediatr Date: 2013-10-14 Impact factor: 2.638

Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus.

Review 1. Etanercept (Enbrel): update on therapeutic use.

2. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

3. Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages.

4. Metabolic effects of tumour necrosis factor alpha in NMRI mice.

1. Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.

Review 2. Drug-induced hypoglycaemia: an update.

Review 3. Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

4. Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series.

5. Refractory rheumatoid factor positive polyarthritis in a female adolescent already suffering from type 1 diabetes mellitus and Hashimoto's thyroiditis successfully treated with etanercept.

Review 6. Psoriasis comorbidities: complications and benefits of immunobiological treatment.

7. Effects of Adalimumab, an Anti-tumour Necrosis Factor-Alpha (TNF-α) Antibody, on Obese Diabetic Rats.

8. Current awareness: pharmacoepidemiology and drug safety.

9. Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes.

Review 10. Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review.